Teva Pharmaceutical Industries TEVA
NYSE TEVA
$42.60 +0.85 (+2.04%)
At close: Nov 6, 2026 · 4:00 PM EST

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Return on Capital Employed [ROCE] was 5.85% in Q3 2026, down 0.56 percentage points from 6.41% a year earlier and down 0.74 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Teva Pharmaceutical Industries came in at 8.11%, up 9.17 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +16.85 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -1.06% in FY2024 (-2.43 pp), 1.37% in FY2023 (+7.77 pp), -6.39% in FY2022 (-10.89 pp) and 4.50% in FY2021 (+13.24 pp).
  • The Q3 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q2 2025.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +2.76 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2021 (a gain of 14.32 percentage points); the worst was Q4 2022 (a drop of 11.40 percentage points).
  • Per Business Quant data, TEVA's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was 6.60% (Q2 2026), 8.52% (Q1 2026) and 8.03% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.52%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 21.60%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.33%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 9.91%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -6.15%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 11.32%
10 Teva Pharmaceutical Industries 49.58 Bn 34.55 Bn 2.44 Bn 5.85%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.85%
Jun 30, 2026 6.60%
Mar 31, 2026 8.52%
Dec 31, 2025 8.03%
Sep 30, 2025 6.41%
Jun 30, 2025 3.26%
Mar 31, 2025 1.57%
Dec 31, 2024 -1.09%
Sep 30, 2024 1.74%
Jun 30, 2024 3.02%
Mar 31, 2024 0.78%
Dec 31, 2023 1.42%
Sep 30, 2023 -4.05%
Jun 30, 2023 -3.76%
Mar 31, 2023 -4.49%
Dec 31, 2022 -6.72%
Sep 30, 2022 -3.51%
Jun 30, 2022 -2.76%
Mar 31, 2022 1.59%
Dec 31, 2021 4.67%
API Access

Teva Pharmaceutical Industries Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY